Pediatric hereditary angioedema: an update [version 1; referees: 2 approved]
Hereditary angioedema (HAE) with C1-inhibitor (C1-Inh) deficiency (C1-Inh-HAE) is a rare, life-threatening, and disabling genetic disorder characterized by self-limited tissue swelling caused by deficiency or dysfunction of C1-Inh. Our aim in this update is to discuss new advances in HAE therapy, fo...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2017-07-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/6-1205/v1 |
id |
doaj-fe3d743497894ac2be1953b7d362aff2 |
---|---|
record_format |
Article |
spelling |
doaj-fe3d743497894ac2be1953b7d362aff22020-11-25T03:50:53ZengF1000 Research LtdF1000Research2046-14022017-07-01610.12688/f1000research.11320.112217Pediatric hereditary angioedema: an update [version 1; referees: 2 approved]Geetika Sabharwal0Timothy Craig1Division of Pulmonary, Allergy and Critical Care, Department of Allergy and Immunology, Penn State University, Milton S. Hershey Medical Center, Hershey, PA, USADivision of Pulmonary, Allergy and Critical Care, Department of Allergy and Immunology, Penn State University, Milton S. Hershey Medical Center, Hershey, PA, USAHereditary angioedema (HAE) with C1-inhibitor (C1-Inh) deficiency (C1-Inh-HAE) is a rare, life-threatening, and disabling genetic disorder characterized by self-limited tissue swelling caused by deficiency or dysfunction of C1-Inh. Our aim in this update is to discuss new advances in HAE therapy, focusing mainly on the various treatment options that have become available recently and also drugs that are under trial for prophylaxis to prevent attacks. There is a paradigm shift to where the treatment of HAE is headed, focusing now on prophylactic treatment rather than abortive management.https://f1000research.com/articles/6-1205/v1Clinical ImmunologyEndocrine & Metabolic PharmacologyImmunopharmacology & Hematologic PharmacologyInnate ImmunityMedical GeneticsPediatric Hematology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Geetika Sabharwal Timothy Craig |
spellingShingle |
Geetika Sabharwal Timothy Craig Pediatric hereditary angioedema: an update [version 1; referees: 2 approved] F1000Research Clinical Immunology Endocrine & Metabolic Pharmacology Immunopharmacology & Hematologic Pharmacology Innate Immunity Medical Genetics Pediatric Hematology |
author_facet |
Geetika Sabharwal Timothy Craig |
author_sort |
Geetika Sabharwal |
title |
Pediatric hereditary angioedema: an update [version 1; referees: 2 approved] |
title_short |
Pediatric hereditary angioedema: an update [version 1; referees: 2 approved] |
title_full |
Pediatric hereditary angioedema: an update [version 1; referees: 2 approved] |
title_fullStr |
Pediatric hereditary angioedema: an update [version 1; referees: 2 approved] |
title_full_unstemmed |
Pediatric hereditary angioedema: an update [version 1; referees: 2 approved] |
title_sort |
pediatric hereditary angioedema: an update [version 1; referees: 2 approved] |
publisher |
F1000 Research Ltd |
series |
F1000Research |
issn |
2046-1402 |
publishDate |
2017-07-01 |
description |
Hereditary angioedema (HAE) with C1-inhibitor (C1-Inh) deficiency (C1-Inh-HAE) is a rare, life-threatening, and disabling genetic disorder characterized by self-limited tissue swelling caused by deficiency or dysfunction of C1-Inh. Our aim in this update is to discuss new advances in HAE therapy, focusing mainly on the various treatment options that have become available recently and also drugs that are under trial for prophylaxis to prevent attacks. There is a paradigm shift to where the treatment of HAE is headed, focusing now on prophylactic treatment rather than abortive management. |
topic |
Clinical Immunology Endocrine & Metabolic Pharmacology Immunopharmacology & Hematologic Pharmacology Innate Immunity Medical Genetics Pediatric Hematology |
url |
https://f1000research.com/articles/6-1205/v1 |
work_keys_str_mv |
AT geetikasabharwal pediatrichereditaryangioedemaanupdateversion1referees2approved AT timothycraig pediatrichereditaryangioedemaanupdateversion1referees2approved |
_version_ |
1724490084692000768 |